共 101 条
[1]
Tosur M(2020)The effect of ethnicity in the rate of beta-cell functional loss in the first 3 years after type 1 diabetes diagnosis J Clin Endocrinol Metab 105 e4393-e4406
[2]
Cleves MA(1987)Effects of age, duration, and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT) J Clin Endocrinol Metab 65 30-36
[3]
Sosenko JM(2003)Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial Diabetes Care 26 832-836
[4]
Steffes MW(2009)Fasting plasma C-peptide and micro-and macrovascular complications in a large clinic-based cohort of Type 1 diabetic patients Diabetes Care 32 301-305
[5]
Sibley S(2015)Prevalence of detectable C-peptide according to age at diagnosis and duration of Type 1 diabetes Diabetes Care 38 476-481
[6]
Jackson M(2014)Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial Diabetes 63 739-748
[7]
Panero F(2008)Rate of beta-cell destruction in Type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years J Clin Endocrinol Metab 93 4759-4766
[8]
Novelli G(2020)Biological activity of C-peptide in microvascular complications of Typ1 diabetes—time for translational studies or back to the basics? Int J Mol Sc 21 9723-328
[9]
Zucco C(2009)C-peptide in the natural history of Type 1 Diabetes Diabetes Metab Res Ver 25 325-470
[10]
Davis AK(2012)Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay Diabetes Care 35 465-191